Literature DB >> 14973391

The normal and malignant mammary gland: a fresh look with ER beta onboard.

M Warner1, S Saji, J A Gustafsson.   

Abstract

Estrogens are important for the development and function of the normal mammary gland as well as for development of mammary cancer. The frontline therapy for treatment of estrogen receptor (ER alpha) positive breast cancer is antiestrogens. A second estrogen receptor (ER beta) is also expressed in the breast but it has not been measured because it is not detected by the immunoassays used to detect ER alpha. In many cell systems ER beta has actions which are opposite to those of ER alpha and this finding has raised questions about the role of ER beta in the development and treatment of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 14973391     DOI: 10.1023/a:1009598828267

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  52 in total

1.  Identification of a splice variant of the rat estrogen receptor beta gene.

Authors:  S Chu; P J Fuller
Journal:  Mol Cell Endocrinol       Date:  1997-09-19       Impact factor: 4.102

2.  Population attributable fraction estimation for established breast cancer risk factors: considering the issues of high prevalence and unmodifiability.

Authors:  B Rockhill; C R Weinberg; B Newman
Journal:  Am J Epidemiol       Date:  1998-05-01       Impact factor: 4.897

Review 3.  Therapeutic potential of selective estrogen receptor modulators.

Authors:  J A Gustafsson
Journal:  Curr Opin Chem Biol       Date:  1998-08       Impact factor: 8.822

4.  A novel isoform of rat estrogen receptor beta with 18 amino acid insertion in the ligand binding domain as a putative dominant negative regular of estrogen action.

Authors:  K Maruyama; H Endoh; H Sasaki-Iwaoka; H Kanou; E Shimaya; S Hashimoto; S Kato; H Kawashima
Journal:  Biochem Biophys Res Commun       Date:  1998-05-08       Impact factor: 3.575

5.  An estrogen-responsive element derived from the 5' flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells.

Authors:  L Klein-Hitpass; M Schorpp; U Wagner; G U Ryffel
Journal:  Cell       Date:  1986-09-26       Impact factor: 41.582

6.  Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta.

Authors:  G B Tremblay; A Tremblay; N G Copeland; D J Gilbert; N A Jenkins; F Labrie; V Giguère
Journal:  Mol Endocrinol       Date:  1997-03

7.  Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha.

Authors:  K Pettersson; K Grandien; G G Kuiper; J A Gustafsson
Journal:  Mol Endocrinol       Date:  1997-09

Review 8.  Legumes and soybeans: overview of their nutritional profiles and health effects.

Authors:  M J Messina
Journal:  Am J Clin Nutr       Date:  1999-09       Impact factor: 7.045

9.  Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta.

Authors:  J Sun; M J Meyers; B E Fink; R Rajendran; J A Katzenellenbogen; B S Katzenellenbogen
Journal:  Endocrinology       Date:  1999-02       Impact factor: 4.736

10.  Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.

Authors:  G G Kuiper; J G Lemmen; B Carlsson; J C Corton; S H Safe; P T van der Saag; B van der Burg; J A Gustafsson
Journal:  Endocrinology       Date:  1998-10       Impact factor: 4.736

View more
  3 in total

1.  Activation of the mTOR pathway by low levels of xenoestrogens in breast epithelial cells from high-risk women.

Authors:  William H Goodson; Maria Gloria Luciani; S Aejaz Sayeed; Ian M Jaffee; Dan H Moore; Shanaz H Dairkee
Journal:  Carcinogenesis       Date:  2011-09-01       Impact factor: 4.944

2.  Oestrogen receptor beta and neoadjuvant therapy with tamoxifen: prediction of response and effects of treatment.

Authors:  W R Miller; T J Anderson; J M Dixon; P T K Saunders
Journal:  Br J Cancer       Date:  2006-05-08       Impact factor: 7.640

Review 3.  Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER.

Authors:  Rainer Girgert; Günter Emons; Carsten Gründker
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-09       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.